By CHAD BRAY
Rottapharm said that it expects to price its offering of 50 million shares at 7.25 euros to 9 euros a share, valuing the company at up to 1.8 million euros, or about $2.46 billion.
Published: July 1, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1z5zgQc
via IFTTT
from WordPress http://ift.tt/1kb1H5e
via IFTTT
No comments:
Post a Comment